CRIS Current Research Information System

MUSIANI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.588
AS - Asia 5.143
EU - Europa 4.755
AF - Africa 323
SA - Sud America 224
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 16.039
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.543
CN - Cina 1.712
SG - Singapore 1.415
GB - Regno Unito 1.357
VN - Vietnam 1.080
DE - Germania 627
IT - Italia 573
UA - Ucraina 569
SE - Svezia 553
HK - Hong Kong 325
IN - India 307
RU - Federazione Russa 301
FR - Francia 212
IE - Irlanda 173
BR - Brasile 164
JP - Giappone 119
ZA - Sudafrica 99
EE - Estonia 93
KR - Corea 87
CH - Svizzera 81
TG - Togo 78
SC - Seychelles 54
CI - Costa d'Avorio 51
NL - Olanda 43
BG - Bulgaria 41
BE - Belgio 35
CA - Canada 34
IR - Iran 30
NG - Nigeria 30
AR - Argentina 27
FI - Finlandia 25
GR - Grecia 18
AT - Austria 16
JO - Giordania 16
RO - Romania 13
ID - Indonesia 11
UZ - Uzbekistan 10
EC - Ecuador 7
LB - Libano 7
MX - Messico 7
CO - Colombia 6
IQ - Iraq 6
PL - Polonia 6
PY - Paraguay 6
CL - Cile 5
BD - Bangladesh 4
EG - Egitto 4
EU - Europa 4
UY - Uruguay 4
AZ - Azerbaigian 3
DZ - Algeria 3
ES - Italia 3
IL - Israele 3
LT - Lituania 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
KZ - Kazakistan 2
PE - Perù 2
PR - Porto Rico 2
TR - Turchia 2
AL - Albania 1
AU - Australia 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
SM - San Marino 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 16.039
Salva come PNG Salva come JPEG
Città #
Southend 1.162
Singapore 881
Ashburn 553
Chandler 541
Dong Ket 501
Fairfield 455
Jacksonville 430
Hong Kong 323
Hefei 316
Wilmington 260
Princeton 246
Ann Arbor 237
Woodbridge 236
Seattle 228
Houston 214
Beijing 186
Dublin 173
Boardman 164
Cambridge 160
Santa Clara 139
Ho Chi Minh City 119
Tokyo 119
Westminster 119
Padova 118
Nanjing 108
Berlin 94
Hanoi 89
Seoul 85
Los Angeles 81
Medford 79
Lomé 78
Bern 74
Buffalo 72
Mülheim 69
Saint Petersburg 66
Milan 65
New York 59
Shenyang 55
Jinan 52
Mahé 52
Abidjan 51
Changsha 43
Sofia 41
Redwood City 40
Bengaluru 37
Nanchang 37
Tianjin 36
Bologna 35
Brussels 35
Dallas 35
Shanghai 35
Zhengzhou 32
Guangzhou 31
Abeokuta 30
Hebei 28
Florence 26
Hangzhou 26
Verona 26
Bremen 24
Jiaxing 24
Helsinki 23
Des Moines 21
Olalla 20
San Diego 20
Haiphong 19
Taizhou 19
Dearborn 17
Paris 17
Toronto 17
Amman 16
Norwalk 16
Phoenix 15
Kunming 14
Ningbo 14
Redondo Beach 14
Frankfurt am Main 13
San Venanzo 13
Wuhan 13
Yubileyny 13
Haikou 12
Hyderabad 12
Rome 12
Taiyuan 12
Falls Church 11
Kuban 11
Pune 11
São Paulo 11
Ardabil 10
Chengdu 10
London 10
Rio de Janeiro 10
Tappahannock 10
Turin 10
Vienna 10
Curitiba 9
Da Nang 9
Falkenstein 9
Lanzhou 9
Shenzhen 9
Shijiazhuang 9
Totale 10.260
Salva come PNG Salva come JPEG
Nome #
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 229
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 219
Bio- and chemiluminescence imaging in analytical chemistry 202
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 199
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 194
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 191
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 189
A miniaturized multiplexed analytical device with chemiluminescence "contact" imaging detection for diagnostic applications 189
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 185
Bio-chemiluminescent miniaturized biosensors 184
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 184
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 182
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 178
Analysis of HPV16 E6*I-II transcripts in cervical samples 178
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 177
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 176
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 175
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 174
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 174
A proteomic approach to the analysis of B19 capsid proteins 171
Combined fluorescent DNA in situ hybridization and chemiluminescent immunohistochemistry for the co-localization of mucosal human papillomavirus and malignant melanoma 169
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 166
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 164
Recurrent erythema in patients with long-term parvovirus B19 infection 162
Analisi della competenza funzionale di cloni genomici di parvovirus B19 160
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 159
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 159
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 157
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 154
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 154
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 152
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 151
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 150
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 150
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 150
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 150
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 149
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 148
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 145
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 144
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 143
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 143
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 142
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 141
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 141
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 141
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 140
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 139
Analysis of the functional competence of genomic clones of Parvovirus B19 138
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 137
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 137
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 136
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 136
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 136
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 136
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 136
Parvovirus B19-derived fetal complications following gestational infection. 135
No correlation between cytomegalovirus and alopecia areata [2] 134
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 133
Evidence of human bocavirus viremia in healthy blood donors. 133
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 132
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 132
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 131
Diagnosi virologica di infezione da papillomavirus umani 130
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la colocalizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 130
Molecular luminescence imaging 130
Human papillomavirus in melanoma: reply from authors 128
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 127
Implicazioni nella progressione della patologia cervicale 127
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 127
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 126
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 123
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 123
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 121
Catalytic partial oxidation of CH4-H2mixtures over Ni foams modified with Rh and Pt 121
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 119
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 119
Development of a miniaturized analytical device employing luminescence “contact” imaging detection for parvovirus B19 infection diagnosis 119
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 119
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 118
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 118
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 118
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 117
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 117
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 117
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 116
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 116
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 115
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 112
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 111
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 109
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 107
Quantitative immunohistochemistry and in situ hybridisation imaging procedures with luminescence detection: a new potential diagnostic tool 106
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 106
Detection of parvovirus B19 IgG: choice of antigens and serological tests 105
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 103
Multiplex chemiluminescence microscope imaging of P16INK4A and HPV DNA as biomarker of cervical neoplasia 103
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 103
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 102
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 97
Totale 14.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.280 0 0 0 0 0 0 37 106 121 107 108 801
2021/20222.130 164 110 140 224 179 116 22 116 67 226 354 412
2022/20232.297 247 339 126 272 177 139 57 137 358 45 236 164
2023/2024798 42 94 39 128 44 165 108 63 18 33 21 43
2024/20252.057 80 359 221 144 304 112 225 45 17 53 60 437
2025/20262.938 350 712 536 427 605 303 5 0 0 0 0 0
Totale 16.292